Published in Transplantation on April 15, 2010
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes. Transplantation (2010) 0.84
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transpl Int (2014) 0.80
Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease. J Immunol Res (2014) 0.79
Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol. BMC Cardiovasc Disord (2011) 0.78
Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS One (2015) 0.78
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study. J Transplant (2014) 0.77
The impact of abnormal glucose regulation on arterial stiffness at 3 and 15 months after kidney transplantation. Diabetol Metab Syndr (2014) 0.76
BP targets in renal transplant recipients: too high or too low? J Am Soc Nephrol (2014) 0.75
New onset diabetes after transplantation: Not another acronym! JRSM Open (2015) 0.75
Long term evolution of endothelial function during kidney transplantation. BMC Nephrol (2016) 0.75
Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States. Transplant Direct (2017) 0.75
Active video gaming in patients with renal transplant: a pilot study. Transplant Res (2014) 0.75
Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center. Diabetol Metab Syndr (2015) 0.75
Incidence of cardiovascular events and associated risk factors in kidney transplant patients: a competing risks survival analysis. BMC Cardiovasc Disord (2017) 0.75
Chapter 2: Pharmacological cholesterol-lowering treatment in adults. Kidney Int Suppl (2011) (2013) 0.75
Longitudinal assessment of cardiac morphology and function following kidney transplantation. Clin Transplant (2016) 0.75
Renal Function in Kidney and Liver Transplant Recipients After A 130-km Road Cycling Race. Transplant Direct (2015) 0.75
Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center. J Nephrol (2017) 0.75
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med (2014) 2.02
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol (2010) 1.89
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol (2014) 1.57
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant (2008) 1.55
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Post-kidney transplant weight change as marker of poor survival outcomes. Transplantation (2008) 1.46
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int (2010) 1.45
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Waiting time and outcome of kidney transplantation in adolescents. Transplantation (2006) 1.44
Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) (2011) 1.41
Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transpl Int (2010) 1.39
Racial disparities in pediatric kidney transplantation in New Zealand. Pediatr Transplant (2014) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl (2004) 1.26
Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation (2007) 1.26
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2010) 1.24
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant (2010) 1.24
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant (2011) 1.23
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int (2010) 1.22
Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation (2005) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol (2009) 1.16
Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis (2011) 1.15
Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis (2009) 1.15
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Am J Kidney Dis (2007) 1.14
IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol (2008) 1.11
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Albuminuria: marker or target in indigenous populations. Kidney Int Suppl (2004) 1.10
Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol (2012) 1.10
Frequency, etiology and treatment of childhood end-stage kidney disease in Australia and New Zealand. Pediatr Nephrol (2009) 1.09
Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant (2009) 1.09
Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int (2011) 1.05
The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. Transplantation (2012) 1.03
The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol (2012) 1.02
Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis (2004) 1.02
Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transplant (2012) 1.01
Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One (2011) 1.01
Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.01
Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disord (2010) 0.99
Day-to-day variability in spot urine albumin-creatinine ratio. Am J Kidney Dis (2013) 0.98
Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant (2003) 0.98
Home hemodialysis in Australia: current perspective. Hemodial Int (2008) 0.98
Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton) (2012) 0.97
Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrol Dial Transplant (2012) 0.96
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2015) 0.96
Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis (2011) 0.94
Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. Am J Public Health (2008) 0.94
Knowledge deficit of patients with stage 1-4 CKD: a focus group study. Nephrology (Carlton) (2014) 0.93
Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation (2007) 0.93
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrology (Carlton) (2007) 0.93
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney Int (2012) 0.93
Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia. Pediatr Nephrol (2010) 0.92
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol (2009) 0.92
Prospective psychosocial monitoring of living kidney donors using the Short Form-36 health survey: results at 12 months. Transplantation (2004) 0.92
Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis. Nephrol Dial Transplant (2009) 0.92
No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer (2010) 0.92
Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations. Nephrol Dial Transplant (2005) 0.91
Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy. Hum Immunol (2011) 0.90